Roux-en-Y胃旁路术操作细节改良及胆胰支、食物支长度的个体化选择

陈宇涵, 胡嵩浩, 王存川, 董志勇

中国实用外科杂志 ›› 2026, Vol. 46 ›› Issue (9) : 1204-1208.

PDF(1350 KB)
PDF(1350 KB)
中国实用外科杂志 ›› 2026, Vol. 46 ›› Issue (9) : 1204-1208. DOI: 10.19538/j.cjps.issn1005-2208.2026.09.08
专题笔谈·减重手术的修正手术及远期并发症处理

Roux-en-Y胃旁路术操作细节改良及胆胰支、食物支长度的个体化选择

作者信息 +

Refinement of operative details and individualized selection of biliopancreatic and alimentary limb lengths in Roux-en-Y gastric bypass

Author information +
文章历史 +

摘要

Roux-en-Y胃旁路术的近期安全性和远期疗效不仅取决于术式选择,还取决于规范化操作、合理设计肠袢长度及终身营养管理。胃囊形态不当、吻合口血供不足或张力过高、肠袢方向错误及系膜裂孔关闭不全,可导致漏、出血、狭窄、梗阻和内疝;小肠旷置不足可能影响减重和代谢改善,过度旷置则会增加蛋白质-能量营养不良、贫血及微量营养素缺乏风险。胃囊制作应兼顾容积、形态、血供及与残胃的完整分隔,小肠测量须统一工具、起止点和牵拉程度,胃空肠及空肠空肠吻合应确保血供可靠、口径适宜且无张力,并常规关闭系膜裂孔。多数初次近端胃旁路术可将胆胰支50~100 cm、食物支100~150 cm作为参考;对于代谢需求较高且营养风险较低者,可选择性将胆胰支延长至100~150 cm。强化旁路或修正手术应测量全小肠,综合评估共同通道、总食物通道、营养储备及随访依从性。肠袢长度的个体化选择必须以规范操作为基础,并与终身营养补充和生化监测相结合,以兼顾代谢获益与远期营养安全。

Abstract

The short-term safety and long-term efficacy of Roux-en-Y gastric bypass depend not only on procedure selection but also on standardized operative technique, appropriate limb-length design, and lifelong nutritional management. An improperly shaped gastric pouch, inadequate anastomotic perfusion or excessive tension, incorrect limb orientation, and incomplete closure of mesenteric defects may result in leakage, bleeding, stenosis, obstruction, or internal hernia. Insufficient small-bowel bypass may compromise weight loss and metabolic improvement, whereas excessive bypass increases the risks of protein-energy malnutrition, anemia, and micronutrient deficiencies. Gastric-pouch construction should balance volume, configuration, perfusion, and complete separation from the remnant stomach. Small-bowel measurement requires standardized instruments, start and end points, and traction. Gastrojejunostomy and jejunojejunostomy should have adequate perfusion, an appropriate diameter, and minimal tension, and mesenteric defects should be routinely closed. For most primary proximal procedures, a biliopancreatic limb of 50-100 cm and an alimentary limb of 100-150 cm are practical reference ranges. In patients with greater metabolic needs and a low nutritional risk, selective lengthening of the biliopancreatic limb to 100-150 cm may be considered. More intensive bypass or revisional surgery requires measurement of the total small-bowel length and integrated assessment of the common channel, total alimentary limb length, nutritional reserve, and adherence to follow-up. Individualized limb-length selection must be based on standardized technique and combined with lifelong nutritional supplementation and biochemical monitoring to balance metabolic benefits against long-term nutritional safety.

关键词

肥胖症 / 减重代谢手术 / Roux-en-Y胃旁路术 / 胆胰支 / 个体化治疗

Key words

obesity / metabolic and bariatric surgery / Roux-en-Y gastric bypass / biliopancreatic limb / individualized treatment

引用本文

导出引用
陈宇涵, 胡嵩浩, 王存川, 等. Roux-en-Y胃旁路术操作细节改良及胆胰支、食物支长度的个体化选择[J]. 中国实用外科杂志. 2026, 46(9): 1204-1208 https://doi.org/10.19538/j.cjps.issn1005-2208.2026.09.08
CHEN Yu-han, HU Song-hao, WANG Cun-chuan, et al. Refinement of operative details and individualized selection of biliopancreatic and alimentary limb lengths in Roux-en-Y gastric bypass[J]. Chinese Journal of Practical Surgery. 2026, 46(9): 1204-1208 https://doi.org/10.19538/j.cjps.issn1005-2208.2026.09.08
中图分类号: R6   

参考文献

[1]
Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass[J]. N Engl J Med, 2017, 377(12):1143-1155.DOI:10.1056/NEJMoa1700459.
[2]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会, 中国成人教育协会医学继续教育专业委员会肥胖代谢委员会. 腹腔镜Roux-en-Y胃旁路术规范化手术操作指南(2019版)[J/CD]. 中华肥胖与代谢病电子杂志, 2019, 5(2):63-69.DOI:10.3877/cma.j.issn.2095-9605.2019.02.001.
[3]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会(CSMBS). 精准肥胖代谢外科手术中国专家共识(2022版)[J]. 中华胃肠外科杂志, 2022, 25(10):841-851.DOI:10.3760/cma.j.cn441530-20220717-00315.
[4]
胡嵩浩, 董志勇, 王存川. 减重代谢手术的规范化与术式创新[J]. 外科理论与实践, 2020, 25(5):361-363.DOI:10.16139/j.1007-9610.2020.05.001.
[5]
Aleassa EM, Papasavas P, Augustin T, et al. American Society for Metabolic and Bariatric Surgery literature review on the effect of Roux-en-Y gastric bypass limb lengths on outcomes[J]. Surg Obes Relat Dis, 2023, 19(7):755-762.DOI:10.1016/j.soard.2023.04.298.
This literature review is issued by the American Society for Metabolic and Bariatric Surgery regarding limb lengths in Roux-en-Y gastric bypass (RYGB) and their effect on metabolic and bariatric outcomes. Limbs in RYGB consist of the alimentary and biliopancreatic limbs and the common channel. Variation of limb lengths in primary RYGB and as a revisional option for weight recurrence after RYGB are described in this review.Copyright © 2023. Published by Elsevier Inc.
[6]
Gan J, Wang Y, Zhou X. Whether a short or long alimentary limb influences weight loss in gastric bypass: A systematic review and meta-analysis[J]. Obes Surg, 2018, 28(11):3701-3710. DOI:10.1007/s11695-018-3475-6.
Roux-en-Y gastric bypass, the most commonly performed procedure in bariatric surgery, still lacks a consensus on whether alimentary limb length (ALL) influences weight loss. Studies were identified by searching multiple electronic databases. Studies with enough data including body mass index (BMI) loss and percent excess weight loss (% EWL) were eligible. The statistical analysis was performed with Stata 14.0. In total, eight studies with 1714 patients were included. The meta-analysis suggested that short ALLs weakened the efficacy of Roux-en-Y gastric bypass in terms of BMI loss (standard mean deviation (SMD), - 0.33 [95% confidence intervals (CI), - 0.60, - 0.05], p = 0.021) with 3 years of follow-up and % EWL (SMD, - 0.17 [95% CI, - 0.31, - 0.04], p = 0.013) with 2 years of follow-up. The subgroup analysis demonstrated that the group with a BMI ≥ 50 kg/m had a significant SMD between the use of short and the standard ALLs (- 0.71 [95% CI, - 1.07, - 0.35], p = 0.000), while the subgroup with a BMI < 50 kg/m (SMD, - 0.29 [95% CI, - 0.78, 0.20], p = 0.247) did not. Compared with a standard ALL (130-150 cm), a short ALL (40-100 cm) may reduce the efficacy of the Roux-en-Y gastric bypass surgery, while a long ALL (170-250 cm) did not significantly improve the effects in terms of BMI loss and % EWL. In addition, a potential view of the meta-analysis indicated patients with a BMI < 50 kg/m might get more benefits with a short ALL, while those patients with a BMI ≥ 50 kg/m might benefit more from a standard ALL.
[7]
Kamocka A, Chidambaram S, Erridge S, et al. Length of biliopancreatic limb in Roux-en-Y gastric bypass and its impact on postoperative outcomes in metabolic and obesity surgery: Systematic review and meta-analysis[J]. Int J Obes(Lond), 2022, 46(11):1983-1991. DOI:10.1038/s41366-022-01186-0.
[8]
Wang A, Poliakin L, Sundaresan N, et al. The role of total alimentary limb length in Roux-en-Y gastric bypass: A systematic review[J]. Surg Obes Relat Dis, 2022, 18(4):555-563.DOI:10.1016/j.soard.2021.08.022.
Roux-en-Y gastric bypass (RYGB) is an established surgical treatment for obesity. Variations in limb length during RYGB procedures have been investigated for optimizing weight loss while minimizing nutritional deficiencies. The role of the total alimentary limb length (TALL; Roux limb plus common channel [CC]), however, is poorly defined.Compare TALL in RYGB procedures for weight loss outcomes and malnutrition.Systematic review.Ovid Medline and PubMed databases were searched for entries between 1993 and 2020. Search terms included "gastric bypass" and "TALL." Two independent reviewers screened the results.A total of 21 studies measured TALL in RYGB. Of these, 4 of 6 reported a relationship between TALL and weight loss. Additionally, 11 studies reported that when TALL was ≤400 cm and CC <200 cm, 3.4% to 63.6% of patients required limb lengthening for protein malnutrition.The majority of studies on RYGB do not report TALL length. There is some evidence that weight loss is affected by shortening TALL, while a TALL ≤400 cm with CC<200 should be avoided due to severe protein malnutrition. More studies on the effect of TALL are needed.Copyright © 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
[9]
Hamed H, Ali M, Elmahdy Y. Types,safety, and efficacy of limb distalization for inadequate weight loss after Roux-en-Y gastric bypass: A systematic review and meta-analysis with a call for standardized terminology[J]. Ann Surg, 2021, 274(2):271-280. DOI:10.1097/SLA.0000000000004485.
[10]
Mantziari S, Abboretti F, Favre L, et al. Protein malnutrition after Roux-en-Y gastric bypass: A challenging case and scoping review of the literature[J]. Surg Obes Relat Dis, 2023, 19(7):746-754.DOI:10.1016/j.soard.2022.12.032.
[11]
董光龙, 张频, 王勇, 等. 减重与代谢外科手术新术式及评价[J]. 中国实用外科杂志, 2023, 43(5): 537-539. DOI:10.19538/j.cjps.issn1005-2208.2023.05.12.
[12]
Lin H, Baker JW, Meister K, et al. American Society for Metabolic and Bariatric Surgery: Intra-operative care pathway for minimally invasive Roux-en-Y gastric bypass[J]. Surg Obes Relat Dis, 2024, 20(10):895-909.DOI:10.1016/j.soard.2024.06.002.
Clinical care pathways help guide and provide structure to clinicians and providers to improve healthcare delivery and quality. The Quality Improvement and Patient Safety Committee (QIPS) of the American Society for Metabolic and Bariatric Surgery (ASMBS) has previously published care pathways for the performance of laparoscopic sleeve gastrectomy (LSG) and pre-operative care of patients undergoing Roux-en-Y gastric bypass (RYGB).This current RYGB care pathway was created to address intraoperative care, defined as care occurring on the day of surgery from the preoperative holding area, through the operating room, and into the postanesthesia care unit (PACU).PubMed queries were performed from January 2001 to December 2019 and reviewed according to Level of Evidence regarding specific key questions developed by the committee.Evidence-based recommendations are made for care of patients undergoing RYGB including the pre-operative holding area, intra-operative management and performance of RYGB, and concurrent procedures.This document may provide guidance based on recent evidence to bariatric surgeons and providers for the intra-operative care for minimally invasive RYGB.Copyright © 2024 American Society for Metabolic and Bariatric Surgery. All rights reserved.
[13]
Hort A, Cheng Q, Morosin T, et al. Optimal common limb length in Roux-en-Y gastric bypass surgery: Is it important for an ideal outcome?A systematic review[J]. ANZ J Surg, 2023, 93(4):851-858. DOI:10.1111/ans.18192.
In Roux‐en‐Y gastric bypass (RYGB) surgery the common limb length (CLL) is thought to significantly impact on nutritional and metabolic outcomes. However, there has been little focus on establishing routine standardized CLL measurements and its subsequent effect on weight loss and nutritional status. This review aimed to determine the effect of variations of CLL in RYGB surgery on post‐operative outcomes, particularly nutritional status, while considering the need for routine CLL measurements in addition to measuring biliopancreatic limb and alimentary limb lengths.
[14]
Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The importance of the biliopancreatic limb length in gastric bypass: A systematic review[J]. Surg Obes Relat Dis, 2019, 15(1):43-49.DOI:10.1016/j.soard.2018.10.013.
Bariatric surgery has proven to be the most durable treatment for obesity, and it also provides improvement of obesity's associated co-morbidities. Although several mechanisms for its metabolic effects have been studied, the implications of the surgically constructed anatomy on its functioning physiology have not been elucidated. This leaves some uncertainty regarding the recommended limb lengths in Roux-en-Y gastric bypass. The alimentary limb length and function has been studied extensively, but few have studied the influences of the biliopancreatic limb length.To present a systematic review of the literature comparing variations in length of BP limb and results in order to determine BP limb length influence.Academic Hospital, United States.We present a systematic review of all the articles comparing variations of the biliopancreatic limb length and their results.Thirteen articles were identified and analyzed. Most of the articles are prospective studies. Weight loss was superior in longer limbs.Based on our review of the subject, we can conclude that the release of enterohormones in response to a food load in the distal small bowel seems to play an important role in the remission of co-morbidities. Hence, the length of the biliopancreatic limb might affect this process.Copyright © 2018 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
[15]
Kwon Y, Lee S, Kim D, et al. Biliopancreatic limb length as a potential key factor in superior glycemic outcomes after Roux-en-Y gastric bypass in patients with type 2 diabetes: A meta-analysis[J]. Diabetes Care, 2022, 45(12):3091-3100.DOI:10.2337/dc22-0835.
Optimal length of biliopancreatic (BP) and Roux limb in Roux-en-Y gastric bypass (RYGB) for improved glycemic control are not known.To investigate how the lengths of the BP and Roux limbs in RYGB differentially affect postoperative glycemic outcomes in patients with type 2 diabetes.We conducted a systematic literature search using the PubMed, Embase, and the Cochrane Library databases.We included studies that reported glycemic outcomes after RYGB and lengths of the BP and Roux limbs.A total of 28 articles were included for data extraction. Glycemic outcomes after RYGB were assessed on the basis of two definitions: remission and improvement.We categorized the included studies into four groups according to the BP and Roux limb lengths. The type 2 diabetes remission/improvement rates were as follows: long BP-long Roux group 0.80 (95% CI 0.70-0.90)/0.81 (0.73-0.89), long BP-short Roux group 0.76 (0.66-0.87)/0.82 (0.75-0.89), short BP-long Roux group 0.57 (0.36-0.78)/0.64 (0.53-0.75), and short BP-short Roux group 0.62 (0.43-0.80)/0.53 (0.45-0.61). Meta-regression analysis also showed that a longer BP limb resulted in higher postoperative type 2 diabetes remission and improvement rates, whereas a longer Roux limb did not. There was no significant difference or heterogeneity in baseline characteristics, including diabetes-related variables, among the four groups.Not all included studies were randomized controlled trials.Longer BP limb length led to higher rates of type 2 diabetes remission and improvement by 1 year after RYGB in comparisons with the longer Roux limb length.© 2022 by the American Diabetes Association.
[16]
Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition,metabolic, and nonsurgical support of patients undergoing bariatric procedures-2019 update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology,The Obesity Society,American Society for Metabolic & Bariatric Surgery,Obesity Medicine Association,and American Society of Anesthesiologists[J]. Endocr Pract, 2019, 25(suppl 2):1-75. DOI:10.4158/GL-2019-0406.
[17]
O'Kane M, Parretti HM, Pinkney J, et al. British Obesity and Metabolic Surgery Society guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update[J]. Obes Rev, 2020, 21(11):e13087.DOI:10.1111/obr.13087.
[18]
Edwards MA, Powers K, Vosburg RW, et al. American Society for Metabolic and Bariatric Surgery: Postoperative care pathway guidelines for Roux-en-Y gastric bypass[J]. Surg Obes Relat Dis, 2025, 21(5):523-536. DOI:10.1016/j.soard.2025.01.005.
Clinical care pathways and guidelines help guide and provide structure to clinicians and providers to improve healthcare delivery and quality. The Quality Improvement and Patient Safety (QIPS) Committee of the American Society for Metabolic and Bariatric Surgery (ASMBS) has previously published care pathways for the performance of laparoscopic sleeve gastrectomy (LSG), preoperative care of patients undergoing Roux-en-Y gastric bypass (RYGB), and most recently, intraoperative care of patients undergoing RYGB.This current RYGB care pathway guideline was created to address postoperative care guidance.Academic Health Center.For this systematic review, PubMed queries were performed from January 1979 to December 2019. Follow-up queries were performed from January 2020 to July 2024. Peer-reviewed publications were reviewed according to the level of evidence (LoE) regarding specific key questions developed by the QIPS Committee and working group for this pathway.Evidence-based recommendations are made for the postoperative care of patients undergoing RYGB, including recommendations for early postoperative care, postoperative medication management, and long-term postoperative surveillance.This document may provide a structure to providers based on current evidence for the postoperative care of patients with overweight or obesity undergoing RYGB.Copyright © 2025. Published by Elsevier Inc.

脚注

利益冲突 所有作者均声明不存在利益冲突

基金

广东省医学科研基金项目(B2025298)
2025年香港大学粤港代谢医学联合实验室项目

PDF(1350 KB)

Accesses

Citation

Detail

段落导航
相关文章

/

〈 〉